Sen. Patty Murray (D-WA) on Tuesday sent a letter to Mylan CEO Heather Bresch seeking more details, including e-mail communications, on the ways that Mylan attempted to keep Teva’s generic EpiPen from ...
In the latest tussle over the cost of medicines, Teva Pharmaceuticals has filed a lawsuit alleging that a new Colorado program aimed at making epinephrine auto-injectors more affordable violates its ...
Between opioid litigation, price fixing claims, generic carve-out feuds—and, now, a class-action lawsuit alleging copycat launch shenanigans—Teva Pharmaceutical has certainly kept the courts busy in ...
Mylan’s life-saving epinephrine auto-injector EpiPen now has a generic rival, the Food and Drug Administration (FDA) triumphantly announced. Teva Pharmaceuticals USA now has FDA approval to market a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results